DTx WEST 2020

DTx WEST 2020

February 18-20 | San Mateo, CA

Recognizing the  Evidence, Adoption and Value of Digital Therapeutics

Registration Agenda

2020 Partners

Supporters
Sanofi

Sanofi Digital Medicine, under the Chief Medical Office, improves patient outcomes through the development of innovative technology-driven solutions that when combined with drugs, improve treatment efficacy, safety, adherence and overall experience.

Otsuka
Key Numbers of DTx
300+
Attendees

Be part of the 300+ person audience of senior executives who are driving forward the development of Digital Therapeutics

40+
Expert speakers

Learn from the industry-defining speaker faculty, comprised of the pioneers of the industry and the most exciting new-comers

3
years

Launching in 2018, DTx West has been the home for the digital therapeutics industry, acting as the platform for the field to connect, share and grow together.

The DTx Series is my go-to place for staying up-to-date and meeting all of the key players in this promising new digital health category.

Bozidar Jovecevic, VP, Global Head of Digital Therapeutics, Sanofi

I am excited to attend DTx for the fourth time. Whether as a presenter or part of the audience, I learn so much from other Digital Therapeutic executives and attendees about topics ranging from clinical trials to commercialization and everything in between!

Debra Reisenthel, Founding CEO, Palo Alto Health Sciences

I have been to the two editions of DTx West and I’m looking forward to attending DTx East this year. The conference brings together key leaders from across the digital health space to discuss new ideas and ongoing trends that are useful takeaways to bring back to my team.

Pablo Pantaleoni, VP & General Manager, Headspace Health

“Thanks for catalyzing the industry forward in this emerging field. Looking forward to the next one”

Cris de Luca - Global Director, Innovation, Johnson and Johnson Technology

“The DTx Series is a fantastic set of meetings. The quality of the investors, entrepreneurs and companies never fails to impress me, and I always leave having learned a lot”

John Spinale - General Partner, JAZZ Venture Partners

“DTx is an inclusive event, where the participants truly believe that the rising tide will raise all boats”

Mette Dyhrberg - Founder and CEO, MyMee Inc

“DTx is a great event! there is a great mix of digital innovators and large companies which deliver high-quality content. I learn a lot and it’s great to see this community come together and have authentic interactions”

Adam Kaufman - CEO, Canary Health

2020 Speakers

ANAND IYER
ANAND IYER
Chief Strategy Officer
WellDoc
ANAND IYER
Chief Strategy Officer
WellDoc
Jennifer LaGuardia
Jennifer LaGuardia
Senior Director of Behaviour Science
Omada Health
Jennifer LaGuardia
Senior Director of Behaviour Science
Omada Health
VEENA RAO
VEENA RAO
Senior Director, Search & Evaluation, Device Delivery, Connected Systems, & Digital Health
Eli Lilly
VEENA RAO
Senior Director, Search & Evaluation, Device Delivery, Connected Systems, & Digital Health
Eli Lilly
MARK BINI
MARK BINI
VP, New Solutions
Express Scripts
MARK BINI
VP, New Solutions
Express Scripts
JONAS DUSS
JONAS DUSS
Co-Founder, US CEO
Kaia Health
JONAS DUSS
Co-Founder, US CEO
Kaia Health
JENNA CARL
JENNA CARL
VP of Clinical Development & Medical Affairs
Big Health
JENNA CARL
VP of Clinical Development & Medical Affairs
Big Health
SEAN DUFFY
SEAN DUFFY
Co-Founder & CEO
Omada Health
SEAN DUFFY
Co-Founder & CEO
Omada Health
EVERETT CROSLAND
EVERETT CROSLAND
VP, Commercial
AppliedVR
EVERETT CROSLAND
VP, Commercial
AppliedVR
DEREK RICHARDS
DEREK RICHARDS
Chief Science Officer
SilverCloud Health
DEREK RICHARDS
Chief Science Officer
SilverCloud Health
ANIL JINA
ANIL JINA
Chief Medical Officer
Akili Interactive
ANIL JINA
Chief Medical Officer
Akili Interactive
TRINA HISTON
TRINA HISTON
Senior Principal Consultant, Prevention, Wellness & Digital Health
Kaiser Permenente
TRINA HISTON
Senior Principal Consultant, Prevention, Wellness & Digital Health
Kaiser Permenente
ANDY MOLNAR
ANDY MOLNAR
Senior Director, Market Access
Cognoa
ANDY MOLNAR
Senior Director, Market Access
Cognoa
PABLO PANTALEONI
PABLO PANTALEONI
VP and General Manager
Headspace
PABLO PANTALEONI
VP and General Manager
Headspace
CLARE PURVIS
CLARE PURVIS
Director, Behaviour Sciences
Headspace
CLARE PURVIS
Director, Behaviour Sciences
Headspace
EDDIE MARTUCCI
EDDIE MARTUCCI
CEO
Akili Interactive Labs
EDDIE MARTUCCI
CEO
Akili Interactive Labs
ALEX WALDRON
ALEX WALDRON
Chief Commercial Officer
Pear Therapeutics
ALEX WALDRON
Chief Commercial Officer
Pear Therapeutics
ELLI KAPLAN
ELLI KAPLAN
Co-Founder & CEO
Neurotrack
ELLI KAPLAN
Co-Founder & CEO
Neurotrack
CHRIS WASDEN
CHRIS WASDEN
Head of Pharma
Happify
CHRIS WASDEN
Head of Pharma
Happify
DAVID STEVENSON
DAVID STEVENSON
Managing Director
Merck Global Health Innovation Fund
DAVID STEVENSON
Managing Director
Merck Global Health Innovation Fund
EDWARD COX
EDWARD COX
CEO
Dthera Sciences
EDWARD COX
CEO
Dthera Sciences
BRENT VAUGHAN
BRENT VAUGHAN
CEO & Co-Founder
Cognoa
BRENT VAUGHAN
CEO & Co-Founder
Cognoa
VAS BAILEY
VAS BAILEY
Partner
Artis Ventures
VAS BAILEY
Partner
Artis Ventures
SIVA NADARAJAH
SIVA NADARAJAH
Co-Founder & President
JOGO Health
SIVA NADARAJAH
Co-Founder & President
JOGO Health
SHAUNDRA EICHSTADT
SHAUNDRA EICHSTADT
MD, Dermatology Resident
Tufts Medical Centre
SHAUNDRA EICHSTADT
MD, Dermatology Resident
Tufts Medical Centre
MIKAEL ELIASSON
MIKAEL ELIASSON
Global Head of Innovation, Neuroscience Product Development
Genentech
MIKAEL ELIASSON
Global Head of Innovation, Neuroscience Product Development
Genentech
Kenichiro Nishii
Kenichiro Nishii
Lead, Regulatory Affairs and Business Development
CureApp
Kenichiro Nishii
Lead, Regulatory Affairs and Business Development
CureApp
LIZ ROCKETT
LIZ ROCKETT
Director
Kaiser Permanente Ventures
LIZ ROCKETT
Director
Kaiser Permanente Ventures
HAKIM YADI
HAKIM YADI
Co-Founder & CEO
Closed Loop Medicine
HAKIM YADI
Co-Founder & CEO
Closed Loop Medicine
Chris Hogg
Chris Hogg
Chief Commercial Officer
Propeller Health
Chris Hogg
Chief Commercial Officer
Propeller Health
ACACIA PARKS
ACACIA PARKS
Chief Scientist
Happify
ACACIA PARKS
Chief Scientist
Happify
SHARIEF TARAMAN
SHARIEF TARAMAN
Chief Medical Officer
Cognoa
SHARIEF TARAMAN
Chief Medical Officer
Cognoa
PETER HAMES
PETER HAMES
Co-Founder & Chief Executive Officer
Big Health
PETER HAMES
Co-Founder & Chief Executive Officer
Big Health
DEBRA REISENTHEL
DEBRA REISENTHEL
Founding CEO
Palo Alto Health Sciences
DEBRA REISENTHEL
Founding CEO
Palo Alto Health Sciences
ADAM KAUFMAN
ADAM KAUFMAN
President & Chief Executive Officer
Canary Health
ADAM KAUFMAN
President & Chief Executive Officer
Canary Health
JEFFREY ABRAHAM
JEFFREY ABRAHAM
Vice President
Market Access & Trade, Akili Interactive
JEFFREY ABRAHAM
Vice President
Market Access & Trade, Akili Interactive
MEGAN CODER
MEGAN CODER
Executive Director
Digital Therapeutics Alliance
MEGAN CODER
Executive Director
Digital Therapeutics Alliance
ANTOUN NABHAN
ANTOUN NABHAN
Vice President, Corporate Development
Pear Therapeutics
ANTOUN NABHAN
Vice President, Corporate Development
Pear Therapeutics
Ricardo Dos Santos
Ricardo Dos Santos
Entrepreneur in Residence
ResMed
Ricardo Dos Santos
Entrepreneur in Residence
ResMed
PIERRE LEURENT
PIERRE LEURENT
Chief Executive Officer
Voluntis
PIERRE LEURENT
Chief Executive Officer
Voluntis

Summit Workshops

  • The Business of Digital Therapeutics
  • Separating the Digital from the Traditional
The Business of Digital Therapeutics
The Business of Digital Therapeutics - WORKSHOP LEADERS

Debra Reisenthel, President & CEO, Palo Alto Health Sciences
Everett Crosland, VP of Market Access, Reimbursement & Government Affairs, AppliedVR
Jonas Duss, US Chief Executive Officer, Kaia Health
Antoun Nabhan, VP, Corporate Development, Pear Therapeutics

9:00am
Presentation: An Inside Look at the Business of Digital Therapeutics
  • A brief overview of the various business models adopted by digital therapeutic companies
  • An insight into the various routes to market
  • Can DTx companies exist with both FDA and Non-FDA regulated therapeutics or do you have to “pick a side”
9:30am
Breakout Discussions

Splitting into smaller groups, you will discuss the intricacies of the business of digital therapeutics and hear views on how best to successfully run a business in the DTx industry.

  • What are the current business models being used within the industry and which are demonstrating the most success?
  • How do some business models favor certain types of digital therapeutic over others?
  • Can a digital therapeutic company successfully develop and market both FDA & non-FDA regulated digital therapeutics?
  • What are the route to market opportunities available to the DTx industry?
10:30am
Refreshment Break
11:00am
Feedback Discussions

Representative(s) from each group share the main points from their discussion to the whole group. Additional questions from moderators and other group members will be raised during this collaborative discussion. 

Summary thoughts will then be shared by the moderator(s) and all participants will leave with the below:

 

Leave this workshop with:
  • A deeper understanding of the various business models demonstrated by digital therapeutic companies
  • Up-to-date information on business models of varying successes in the current industry
  • A clear understanding of if it’s possible to successfully a dual entity business or if companies truly have to “pick a side”
  • A clear understanding of current routes to market and their intricacies
  • Your questions answered by industry leaders and your peers
12:00pm
End of workshop
Download Agenda
Separating the Digital from the Traditional
Separating the Digital from the Traditional - WORKSHOP LEADERS

Acacia Parks, Chief Scientist, Happify
Jenna Carl, VP of Clinical Development & Medical Affairs, Big Health
Derek Richards, Chief Science Officer, SilverCloud Health
Anil Jina, Chief Medical Officer, Akili Interactive

1:00pm
Presentation: An Introduction into Digital Therapeutic Clinical Trials
  • How do digital therapeutic clinical trials differ from traditional drug trials?
  • An introduction of comparison groups and digital trial design
1:20pm
Panel Discussion: A Deep-Dive into Research Design Considerations

Led by leaders in the industry all with in-depth experience of DTx clinical trials, this panel will dive into clinical trial considerations when designing trials for digital therapeutics

  • What are the requirements when designing digital therapeutic clinical trials?
  • What does the FDA require from clinical trials for them to be acceptable?
  • What does a SHAM/placebo look like in the DTx clinical trial?
  • Should DTx companies and the FDA be working together to produce the right SHAM for each trial?
2:10pm
Freewrite

This is your chance to finalize your notes and prepare questions for the workshop leaders and your peers for after the break!

2:15pm
Refreshment Break
2:45pm
Breakout Discussions

Splitting into smaller groups, each group will discuss their own views on digital therapeutic clinical trials and work on how best to move forward in this space.

  • What are the current issues we face when designing clinical trials for digital therapeutics?
  • What considerations should you have in mind when designing SHAM trials?
  • What are the current guidelines for DTx clinical trials outlined by the FDA?
  • How can we work with governing bodies to ensure DTx clinical trials are both suitable and feasible?
  • What does a suitable and usable SHAM trial look like?
3:20pm
Feedback Discussions

Representatives from each group will share their main points from their discussion with the whole workshop.

Workshop leaders and members from all groups will facilitate the discussion with their own thoughts and questions in this collaborative session.

Summary thoughts will be shared by workshop leaders and all participators will leave with the below:

 

Leave this workshop with:
  • A clear understanding of the clinical trial landscape for digital therapeutics
  • A deeper understanding of how best to build a SHAM/placebo for a DTx clinical trial
  • An understanding of current FDA clinical trial guidelines in the space
  • A greater understanding of important considerations to keep in mind when designing a DTx clinical trial
  • Your questions answered by industry-leading experts and your peers
4:00pm
End of Workshop
Download Agenda

DTx West 2020 agenda

Summit Agenda

  • Day 1: February 18th
  • Day 2: February 19th
Day 1: February 18th
8:00
Day One - Registration, Breakfast & Networking
9:00
Chair’s Opening Remarks & Setting the Scene

Adam Kaufman, President & CEO, Canary Health

9:10
Presentation: What Success Looks like in the Digital Therapeutics Industry
9:35
Panel Discussion: How can we Achieve Replicable Digital Therapeutics Reimbursement

Moderated by Brent Vaughan,  Chief Executive Officer, Cognoa
Sean Duffy, Co-Founder & CEO, Omada Health
Alex Waldron, Chief Strategy Officer, Pear Therapeutics

10:35
Morning Refreshments and Networking
Day 1 will now Split into 2 Tracks

Attendees are welcome to jump between tracks as they choose

Track 1

Defining Evidence Standards for Digital Therapeutics

Chair: Acacia Parks, Chief Scientist, Happify

11:15
Presentation: Is there a Bar of Validation for Digital Therapeutics

Acacia Parks, Chief Scientist, Happify

11:40
Panel Discussion: How does Lack of Clarity in Setting the Bar for Evidence effect Value?

Veena Rao, Senior Director, Search & Evaluation, Device Delivery, Connected Systems & Digital Health, Eli Lilly
Mark Bini, VP, New Solutions, Express Scripts

Track 2

Building the Value Proposition for Digital Therapeutics

Chair: Adam Kaufman, President & CEO, Canary Health

11:15
Presentation: Understanding the Commercial Landscape of Digital Therapeutics

Antoun Nabhan, VP, Corporate Development, Pear Therapeutics

11:40
Panel Discussion: Building the Bridge between Evidence and Value

Jeff Abraham, VP of Market Access & Trade, Akili Interactive
Jennifer LaGuardia, Senior Director of Behaviour Science, Omada Health
Andy Molnar, Senior Director, Market Access, Cognoa
Clare Purvis, Director, Behaviour Sciences, Headspace

12:25
Lunch & Networking
Method of Evidence Generation and Translation
1:55
Presentation: The In's and Out's of Randomized Controlled trials for DTx Clinical Validation

Derek Richards, Chief Science Officer, Silvercloud Health

2:20
Panel Discussion: Understanding the Fundamentals of Demonstrating Clinical Efficacy

Moderated by Sharief Taraman, Chief Medical Office, Cognoa
Debra Reisenthel, President & CEO, Palo Alto Health Sciences
Jenna Carl, VP of Clinical Development & Medical Affairs, Big Health
Jonas Duss, US Chief Executive Officer, Kaia Health

Translating the Value Proposition of Digital Therapeutics
1:55
Presentation: Pharma Partnerships in Action

Chris Wasden, Head of Pharma, Happify Health

2:20
Presentation: Implementing Digital Therapeutics into the Core Efforts alongside Traditional Drugs at Genentech

Mikael Eliasson, Global Head of Innovation, Neuroscience Product Development, Genentech

3:05
Afternoon Refreshments and Networking
3:45
Fireside Chat: The First Large-Scale Acquisition of Digital Therapeutics

Chris Hogg, Chief Commercial Officer, Propeller Health
Ricardo Dos Santos, Entrepeneur in Residence, ResMed

4:30
Panel Discussion: What's going to stop Digital Therapeutics from Breaking Big

Moderated by Ed Cox, CEO, Dthera Sciences
Pierre Leurent
, Founder and CEO, Voluntis
Eddie Martucci, Founder & CEO, Akili Interactive
Megan Coder, Executive Director, Digital Therapeutics Alliance

5:20
Chair's Closing Remarks

Adam Kaufman, President & CEO, Canary Health

5:30
Drinks Reception
6:30
Close of DTx West Day 1
Download Agenda
Day 2: February 19th
8: 00
Day Two - Breakfast & Networking
9:00
Chair’s Opening Remarks

Antoun Nabhan, VP, Corporate Development, Pear Therapeutics

Scaling Digital Therapeutics for World Domination
9:10
Panel Discussion: Scaling Digital Therapeutics for Sustainable Success

Elli Kaplan, Co-Founder & CEO, Neurotrack
Chris Hogg, CCO, Propeller Health
Anand Iyer, Chief Strategy Officer, Welldoc

9:50
Panel Discussion: What do Investors Really Think of Digital Therapeutics

Liz Rockett, Director, Kaiser Permanente Ventures
Vas Bailey, Partner, Artis Ventures
David Stevenson, Managing Director, Merck Global Health Innovation Fund

10:30
Morning Refreshments and Networking
11:00
Presentation: Prescription Digital Therapeutics for Neuro-Muscular Conditions

Siva Nadarajah, Co-Founder & President, JOGO Health

11:25
Presentation: Creating synergy with DTx: How DTx benefits healthcare system stakeholders

Kenichiro Nishii, Lead, Regulatory Affairs and Business Development, CureApp

11:50
Presentation: In-House production of Traditional and Digital Therapeutics for a Combination Approach

Hakim Yadi, Co-Founder & CEO, Closed Loop Medicine

12:15
Lunch and Networking
1:45
Panel Discussion: Digital Therapeutics - Lessons Learned from the Front Line

Trina Histon, Senior Principal Consultant, Prevention, Wellness and Digital Health, Kaiser Permanente
Shaundra Eichstrat, MD, Dermatology Resident, Tufts Medical Centre
Ben Rosner, Assistant Producer, UCSF
Pablo Panteoloni, VP & General Manager of Health, Headspace

2:25
Chairs Closing Remarks

Antoun Nabhan, VP, Corporate Development, Pear Therapeutics

2:35
Close of DTx West 2019
Download Agenda

Partner with us

PARTNERSHIPS
The DTx summits are the premier events for senior executives from DTx companies, Pharma, Investors, HCPs and Payers.

DTx West 2020 is the seventh summit in the DTx series.  We are expecting 300 people at the summit in San Mateo, which is what our attendees and partnersa tell us is the optimum size

We believe that getting the right mix of partners is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world-class audience.

You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.

Get in touch today to learn more and avoid missing out!

Contact Us +
Partner with us

Register for the Event

Early Booking Price expires November 22nd.

For pricing and booking options please click the button to go to the registration page.

Registration